Source:http://linkedlifedata.com/resource/pubmed/id/20059975
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-2-17
|
pubmed:abstractText |
Non-enzymatic glycation of serum apolipoproteins is a main feature of diabetes mellitus under hyperglycemia. Advanced glycation end products are implicated in the development of aging and metabolic syndrome, including premature atherosclerosis in diabetic subjects. ApoA-I is the principal protein constituent of HDL. In this study, glycated human apoA-I (gA-I) by fructation was characterized on functional and structural correlations in lipid-free and lipid-bound states. The gA-I showed more spontaneous multimeric band formation up to pentamer and exhibited slower elution profile with more degraded fragments from fast protein liquid chromatography. The gA-I showed modified secondary structure from fluorescence and circular dichroism analysis. Reconstituted high-density lipoprotein (rHDL) containing the gA-I had less content of phospholipid with a much smaller particle size than those of rHDL-containing nA-I (nA-I-rHDL). The rHDL containing gA-I (gA-I-rHDL) consisted of less molecular number of apoA-I than nA-I-rHDL with decreased alpha-helical content. Treatment of the gA-I-rHDL induced more atherogenic process in macrophage cell and premature senescence in human dermal fibroblast cell. Conclusively, fructose-mediated apoA-I glycation resulted in severe loss of several beneficial functions of apoA-I and HDL regarding anti-senescence and anti-atherosclerosis activities due to a lack of anti-oxidant activity with increased susceptibility of protein degradation and structural modification.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1090-2104
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
12
|
pubmed:volume |
392
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
295-300
|
pubmed:meshHeading |
pubmed-meshheading:20059975-Aging,
pubmed-meshheading:20059975-Apolipoprotein A-I,
pubmed-meshheading:20059975-Atherosclerosis,
pubmed-meshheading:20059975-Cell Aging,
pubmed-meshheading:20059975-Fibroblasts,
pubmed-meshheading:20059975-Fructose,
pubmed-meshheading:20059975-Glycosylation End Products, Advanced,
pubmed-meshheading:20059975-Humans,
pubmed-meshheading:20059975-Lipoproteins, HDL,
pubmed-meshheading:20059975-Macrophages,
pubmed-meshheading:20059975-Protein Structure, Secondary
|
pubmed:year |
2010
|
pubmed:articleTitle |
Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence.
|
pubmed:affiliation |
Aging-associated Vascular Disease Research Center, Yeungnam University, Gyeongsan 712-749, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|